CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-01 | Welch David F Director | Option exercise | +2,259,102 | $0.50 | $1.1M | 9,513,417 |
| 2020-04-01 | Welch David F Director | Option exercise · Convertible Promissory Note | −1,129,551 | 0 | ||
| 2020-03-16 | Colachis Arian GC and Corporate Secretary | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-02-21 | Welch David F Director | Option exercise | +1,819,672 | $0.18 | $328K | 7,072,348 |
| 2020-02-21 | Welch David F Director | Grant or award | +181,967 | 7,254,315 | ||
| 2020-02-21 | Welch David F Director | Returned to the company · Warrant (Right to Buy) | −1,000,000 | 0 | ||
| 2020-02-21 | Welch David F Director | Grant or award · Warrant (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2020-02-21 | Welch David F Director | Returned to the company · Warrant (Right to Buy) | −819,672 | 0 | ||
| 2020-02-21 | Welch David F Director | Grant or award · Warrant (Right to Buy) | +819,672 | 819,672 | ||
| 2020-02-21 | Welch David F Director | Option exercise · Warrant (Right to BuyO | −1,819,672 | 0 | ||
| 2020-02-21 | Eastwood Craig S. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2020-01-31 | Welch David F Director | Purchase · Series D Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 1,000 |
| 2020-01-31 | Welch David F Director | Purchase · Warrants | +500,000 | 500,000 | ||
| 2020-01-18 | TIMMINS ALAN P Director | Grant or award · Stock Option (right to buy) | +36,986 | 36,986 | ||
| 2020-01-06 | Fleming Maura See Remarks | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-12-24 | Pourhassan Nader President & CEO | Grant or award | +225,983 | 387,472 | ||
| 2019-12-24 | Pourhassan Nader President & CEO | Shares withheld for taxes | −70,055 | $0.64 | $45K | 317,417 |
| 2019-12-24 | Mulholland Michael D. SVP-Finance | Grant or award | +153,897 | 241,023 | ||
| 2019-12-24 | Mulholland Michael D. SVP-Finance | Shares withheld for taxes | −56,942 | $0.64 | $36K | 184,081 |
| 2019-12-23 | Welch David F Director | Grant or award | +1,639,344 | 5,252,676 |
Page 16 of 33 · 652 trades